On Friday, April 24, 2026, I had the privilege of being one of six Notre Dame faculty selected to pitch at the inaugural Research Commercialization Grant (RCG) Pitch Event, hosted by the IDEA Center at Notre Dame in Leighton Hall at Innovation Park. The morning brought together external investors, the IDEA Center Advisory Council, and …
Category Archive: Hybrid nanoparticles
Jan 29
Phage-Mimicking Antibacterial Nanoparticles Tackle Group A Streptococcal Infections In Vivo
We are excited to publish on our Phage-mimicking nanoparticles efficiently tackling Group A Streptococcus infections in mouse wound infection models in RSC Nanoscale Advances (https://pubs.rsc.org/en/content/articlepdf/2024/NA/D3NA00620D). Thank you to Prof. Frank Castellino, Prof. Victoria Ploplis, and Deborah Donahue of the W.M. Keck Transgene Center for the in vivo studies. Thanks to Prof. Shaun Lee’s lab (Biology) …
Nov 28
Nallathamby Laboratory in the Press for Novel Approach to CAR-T Therapy
Glad to see that our work on using nanoparticle-based ON-OFF switches for CAR-T cells therapy against solid tumors is getting positive traction in the local media. Here is my interview with Kylie Veleta of Inside Indiana business on what motivates us to keep pushing forward. The website is Indiana business focused. The interview was part …

Recent Comments